AWS
RGEN icon

Atria Wealth Solutions’s Repligen RGEN Stock Holding History

Atria Wealth Solutions’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,971
Closed -$363K – 2045
2024
Q1 		$363K Buy
+1,971
New +$375K ﹤0.01% 1423
2023
Q2 		– Sell
-3,170
Closed -$534K – 1969
2023
Q1 		$534K Sell
3,170
-610
-16% -$109K 0.01% 1097
2022
Q4 		$640K Sell
3,780
-4,209
-53% -$763K 0.01% 963
2022
Q3 		$1.49M Buy
+7,989
New +$1.68M 0.03% 584
2022
Q2 		– Sell
-9,564
Closed -$1.8M – 1851
2022
Q1 		$1.8M Buy
+9,564
New +$1.82M 0.03% 513

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Atria Wealth Solutions's RGEN Position: Q2 2024 in Review

Atria Wealth Solutions sold out of Repligen (RGEN) in Q2 2024, closing a stake of 1,971 shares — an estimated $363K sold.

Atria Wealth Solutions first reported a position in RGEN in Q1 2022 and held it in 5 quarters. The position peaked at $1.8M in Q1 2022. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

  • Atria Wealth Solutions reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
  • Atria Wealth Solutions sold 1,971 Repligen shares in Q2 2024, an estimated $363K.
  • Atria Wealth Solutions first reported a position in Repligen in Q1 2022 and held it in 5 quarters.
  • Atria Wealth Solutions's Repligen position peaked at $1.8M in Q1 2022.
  • 455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on Atria Wealth Solutions's 13F filing for Q2 2024, filed 22 Jul 2024.